| Financial Year |
March 31 2023 |
| Monetary Funds |
985,593,562.54 |
| Held-for-trading Financial Assets |
641,079,090.41 |
| Notes Receivable |
-- |
| Accounts Receivable |
17,808,723.21 |
| Advances to Suppliers |
4,628,093.17 |
| Other Receivables |
6,625,357.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,838,753.30 |
| Dividend Receivable |
-- |
| Inventories |
20,153,625.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
161,703,044.56 |
| Total Current Assets |
1,837,591,497.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,710,530.32 |
| Investment Properties |
-- |
| Fixed Assetes |
485,101,355.40 |
| Under-construction Projects |
10,002,485.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
310,668,120.80 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
623,585.89 |
| Deferred Income Tax Assets |
7,013,006.32 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
969,487,875.94 |
| Total Assets |
2,807,079,373.25 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
126,614,910.91 |
| Accounts Received In Advance |
22,558,003.23 |
| Employee Compensation Payable |
26,255,915.01 |
| Taxes Payable |
15,571,665.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
84,909,806.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,222,017.77 |
| Other Current Liabilities |
4,039,621.49 |
| Sub-Total of Current Liabilities |
341,278,352.81 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
37,519,658.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
172,739,926.35 |
| Total Liabilities |
514,018,279.16 |
| Paid-In Capital(Or Share Stock) |
415,763,000.00 |
| Capital Surplus |
523,522,419.60 |
| Surplus Reserve |
207,881,500.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,100,534,450.18 |
| Minority Stockholder's Interest |
44,131,331.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,248,929,762.72 |
| Owner's Equity（Stockholder's Equity） |
2,293,061,094.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,807,079,373.25 |
